Horsham, United Kingdom

Kamlesh Jagdis Bala

This inventor holds 17 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Novartis Ag, Other. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kamlesh Jagdis Bala. Retrieved from https://idiyas.com/inventor/kamlesh-jagdis-bala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 94.1


 

Average Co-Inventor Count = 7.9

ph-index = 4

Forward Citations = 104(Granted Patents)


Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pyridine Derivatives
Pyrazine Derivatives
Carboxamide Derivatives
Chronic Bronchitis
Cystic Fibrosis
CRTH2 Antagonists
Heterocyclic Compounds
Organic Compounds
Inflammatory Conditions
Allergic Conditions
N-Substituted Heterocycles
Pyrrolopyridine Derivatives
17 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kamlesh Jagdis Bala

Introduction: Kamlesh Jagdis Bala is an accomplished inventor based in Horsham, GB, with a remarkable portfolio of 17 patents. His work primarily focuses on developing novel pharmaceutical compositions aimed at treating various respiratory and gastrointestinal conditions. With a commitment to advancing medical science, Bala continues to make significant contributions to the field of pharmacology.

Latest Patents: Bala's recent patents include groundbreaking inventions such as "Pyridine and Pyrazine Derivative for the Treatment of Chronic Bronchitis." This innovation provides pyridine and pyrazine derivatives designed to restore or enhance the function of both mutant and wild type CFTR, addressing conditions such as cystic fibrosis, chronic obstructive pulmonary disease, and asthma. Additionally, his patent on "Carboxamide Derivatives" outlines a method for producing pharmaceutical compounds that demonstrate effective therapeutic uses. These inventions collectively contribute to enhancing patient care and treatment options.

Career Highlights: Throughout his career, Kamlesh Jagdis Bala has worked with prominent companies, including Novartis AG. His experience in these industry-leading organizations has enriched his understanding and expertise in developing effective therapeutic agents for challenging medical conditions.

Collaborations: Bala has collaborated with esteemed colleagues such as David Andrew Sandham and Lee Edwards. These partnerships have fostered a collaborative environment that encourages innovation and contributes to the advancement of medical research.

Conclusion: Through his inventive spirit and dedication to improving healthcare, Kamlesh Jagdis Bala stands out as a key figure in the field of pharmaceutical innovations. His significant patent portfolio reflects a profound impact on treating various diseases, and his ongoing work promises to further enhance therapies available in the medical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…